Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.6.3757

miR-485 Acts as a Tumor Suppressor by Inhibiting Cell Growth and Migration in Breast Carcinoma T47D Cells  

Anaya-Ruiz, Maricruz (Laboratory of Cellular Biology, Centro de Investigacion Biomedica de Oriente, Instituto Mexicano del Seguro Social)
Bandala, Cindy (Department of Research Support, Instituto Nacional de Rehabilitacion)
Perez-Santos, Jose Luis Martin (Vice-rectory of Research and Postgraduate Studies, Benemerita Universidad Autonoma de Puebla)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.6, 2013 , pp. 3757-3760 More about this Journal
Abstract
MicroRNAs (miRNAs) are small, non-coding RNAs (18-25 nucleotides) that post-transcriptionally modulate gene expression by negatively regulating the stability or translational efficiency of their target mRNAs. In this context, the present study aimed to evaluate the in vitro effects of miR-485 mimics in breast carcinoma T47D cells. Forty-eight hours after T47D cells were transfected with miR-485 mimics, an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was utilized to determine the effects on cell viability. Colony formation and cell migration assays were adopted to determine whether miR-485 affects the proliferation rates and cell migration of breast carcinoma T47D cells. Our results showed that ectopic expression of miR-485 resulted in a significant decrease in cell growth, cell colony formation, and cell migration. These findings suggest that miR-485 might play an important role in breast cancer by suppressing cell proliferation and migration.
Keywords
Breast cancer; microRNA; migration; tumor suppressor;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Kim TH, Kim YK, Kwon Y, et al (2010). Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology, 57, 734-43.   DOI   ScienceOn
2 Lages E, Ipas H, Guttin A, et al (2012). MicroRNAs: molecular features and role in cancer. Front Biosci, 17, 2508-40.   DOI
3 Lee S, and Vasudevan S (2013). Post-transcriptional stimulation of gene expression by microRNAs. Adv Exp Med Biol, 768, 97-126.   DOI   ScienceOn
4 Li S, Meng H, Zhou F, et al (2013). MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract, 209, 179-83.   DOI   ScienceOn
5 Lodes MJ, Caraballo M, Suciu D, et al (2009). Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray. PLoS One, 4, 6229.   DOI   ScienceOn
6 Parpart S, Wang XW (2013). microRNA Regulation and Its Consequences in Cancer. Curr Pathobiol Rep, 1, 71-9.   DOI   ScienceOn
7 Selcuklu SD, Donoghue MT, Rehmet K, et al (2012). MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem, 287, 29516-28.   DOI
8 Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.   DOI   ScienceOn
9 Singh R, Mo YY (2013). Role of microRNAs in breast cancer. Cancer Biol Ther, 14, 201-12.   DOI   ScienceOn
10 Tang J, Ahmad A, Sarkar FH (2012). The role of MicroRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci, 13, 13414-37.   DOI   ScienceOn
11 Wang QY, Tang J, Zhou CX, et al (2012). The down-regulation of miR-129 in breast cancer and its effect on breast cancer migration and motility. Sheng Li Xue Bao, 64, 403-11.
12 Yang H, Cho ME, Li TWH, et al (2013). MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma. J Clin Invest. 123, 285-298.   DOI   ScienceOn
13 Yang L, Sun TT, Wang N (2012). The incidence and mortality trends of female breast cancer in Beijing, China: between 2004 and 2008. Zhonghua Yu Fang Yi Xue Za Zhi, 46, 1009-14.
14 Zhou J, Tian Y, Li J, et al (2013). miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2. Biochem Biophys Res Commun, 433, 207-12.   DOI   ScienceOn
15 Biagioni F, Bossel Ben-Moshe N, Fontemaggi G, et al (2012). miR-10b*, a master inhibitor of the cell cycle, is downregulated in human breast tumours. EMBO Mol Med, 4, 1214-29.   DOI
16 Costa FF, Jared M, Bischof JM, et al (2011). Identification of MicroRNAs as potential prognostic markers in ependymoma. PLoS One, 6, 25114.   DOI
17 Fils-Aime N, Dai M, Guo J, et al (2013). MicroRNA-584 and the Protein Phosphatase and Actin Regulator 1 (PHACTR1), a new signaling route through which transforming growth factor-$\beta$ mediates the migration and actin dynamics of breast cancer cells. J Biol Chem, 288, 11807-23.   DOI   ScienceOn
18 Haghighat S, Akbari M, Ghaffari S (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev, 13, 5525-8.   과학기술학회마을   DOI   ScienceOn
19 Harquail J, Benzina S, Robichaud GA (2012). MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis. Cancer Biomark, 11, 269-80.
20 Hu X, Guo J, Zheng L, et al (2013). The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer. Molec Cancer Res, 11, 240-50.   DOI   ScienceOn
21 Chen CF, He X, Arslan AD, et al (2011). Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase $II\alpha$ and drug responsiveness. Mol Pharmacol, 79, 735-41.   DOI   ScienceOn
22 Imam JS, Plyler JR, Bansal H, et al (2012). Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS One, 7, 52397.   DOI
23 Kala R, Peek GW, Hardy TM, et al (2013). MicroRNAs: an emerging science in cancer epigenetics. J Clin Bioinform, 16, 6-13.